These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 9721018

  • 1. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM, Sanyal S, Van Tol HH.
    Eur J Pharmacol; 1998 Jun 26; 351(3):273-86. PubMed ID: 9721018
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J, Eyrolles L, Bruhwyler J, Delarge J.
    Curr Med Chem; 1998 Apr 26; 5(2):77-100. PubMed ID: 9481035
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D4 receptors and development of newer antipsychotic drugs.
    Kulkarni SK, Ninan I.
    Fundam Clin Pharmacol; 2000 Apr 26; 14(6):529-39. PubMed ID: 11206702
    [Abstract] [Full Text] [Related]

  • 4. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.
    Sanyal S, Van Tol HH.
    J Psychiatr Res; 1997 Apr 26; 31(2):219-32. PubMed ID: 9278187
    [Abstract] [Full Text] [Related]

  • 5. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb 26; 24(1):13-20. PubMed ID: 15027326
    [Abstract] [Full Text] [Related]

  • 6. The discovery of potent and selective dopamine D4 receptor antagonists.
    Faraci WS, Zorn SH, Sanner MA, Fliri A.
    Curr Opin Chem Biol; 1998 Aug 26; 2(4):535-40. PubMed ID: 9736928
    [Abstract] [Full Text] [Related]

  • 7. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb 26; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 8. Dopamine D4 receptors: curiouser and curiouser.
    Strange PG.
    Trends Pharmacol Sci; 1994 Sep 26; 15(9):317-9. PubMed ID: 7992381
    [No Abstract] [Full Text] [Related]

  • 9. The importance of dopamine D4 receptors in the action and development of antipsychotic agents.
    Reynolds GP.
    Drugs; 1996 Jan 26; 51(1):7-11. PubMed ID: 8741229
    [Abstract] [Full Text] [Related]

  • 10. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO.
    Slifstein M, Abi-Dargham A, Girgis RR, Suckow RF, Cooper TB, Divgi CR, Sokoloff P, Leriche L, Carberry P, Oya S, Joseph SK, Guiraud M, Montagne A, Brunner V, Gaudoux F, Tonner F.
    Psychopharmacology (Berl); 2020 Feb 26; 237(2):519-527. PubMed ID: 31773210
    [Abstract] [Full Text] [Related]

  • 11. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G, Knowles MR, Ward-Booth SM, Sinclair HA, Patel S, Marwood R, Emms F, Patel S, Smith A, Seabrook GR.
    J Recept Signal Transduct Res; 1995 Feb 26; 15(1-4):267-81. PubMed ID: 8903944
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P.
    Neuropsychopharmacology; 1992 Dec 26; 7(4):261-84. PubMed ID: 1362057
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
    Jardemark K, Wadenberg ML, Grillner P, Svensson TH.
    Curr Opin Investig Drugs; 2002 Jan 26; 3(1):101-5. PubMed ID: 12054059
    [Abstract] [Full Text] [Related]

  • 14. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S, Seeman P.
    Am J Psychiatry; 2001 Mar 26; 158(3):360-9. PubMed ID: 11229973
    [Abstract] [Full Text] [Related]

  • 15. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H, Ebdrup BH, Fagerlund B, Svarer C, Rasmussen H, Friberg L, Allerup PN, Rostrup E, Pinborg LH, Glenthøj BY.
    Int J Neuropsychopharmacol; 2016 May 26; 19(5):. PubMed ID: 26819282
    [Abstract] [Full Text] [Related]

  • 16. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
    Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR.
    Trends Pharmacol Sci; 1997 Jun 26; 18(6):186-8. PubMed ID: 9226994
    [Abstract] [Full Text] [Related]

  • 17. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
    Futamura T, Ohashi Y, Yano K, Takahashi Y, Haga K, Fukuda T.
    Nihon Yakurigaku Zasshi; 1996 May 26; 107(5):247-53. PubMed ID: 8690306
    [Abstract] [Full Text] [Related]

  • 18. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN.
    Arch Gen Psychiatry; 1997 Mar 26; 54(3):225-32. PubMed ID: 9075463
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
    Lahti RA, Evans DL, Stratman NC, Figur LM.
    Eur J Pharmacol; 1993 Jun 04; 236(3):483-6. PubMed ID: 8102973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.